Alan R. Brooks

1.2k total citations
19 papers, 975 citations indexed

About

Alan R. Brooks is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Alan R. Brooks has authored 19 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in Alan R. Brooks's work include Virus-based gene therapy research (3 papers), Multiple Sclerosis Research Studies (2 papers) and RNA Interference and Gene Delivery (2 papers). Alan R. Brooks is often cited by papers focused on Virus-based gene therapy research (3 papers), Multiple Sclerosis Research Studies (2 papers) and RNA Interference and Gene Delivery (2 papers). Alan R. Brooks collaborates with scholars based in United States, United Kingdom and France. Alan R. Brooks's co-authors include Gabor M. Rubanyi, Peter I. Lelkes, Richard N. Harkins, Hu Sheng Qian, Peiyin Wang, Eric E. Brooks, Peter G. Milner, Dov Shiffman, Christine Chan and Jens Glienke and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

Alan R. Brooks

19 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan R. Brooks United States 10 594 241 177 162 138 19 975
Nicola H. Dryden United Kingdom 13 813 1.4× 167 0.7× 124 0.7× 171 1.1× 117 0.8× 17 1.4k
Massimo Zani Italy 17 731 1.2× 345 1.4× 180 1.0× 154 1.0× 52 0.4× 31 1.1k
Corinna Warburton Canada 13 649 1.1× 179 0.7× 155 0.9× 63 0.4× 111 0.8× 16 1.1k
Aimee Landry United States 10 609 1.0× 322 1.3× 149 0.8× 346 2.1× 118 0.9× 11 1.3k
Sirous Zeinali Iran 18 794 1.3× 202 0.8× 142 0.8× 154 1.0× 87 0.6× 112 1.3k
Masahiro Muto Japan 18 1.4k 2.4× 405 1.7× 212 1.2× 188 1.2× 90 0.7× 54 1.9k
Kenji Tamayose Japan 13 477 0.8× 346 1.4× 178 1.0× 123 0.8× 69 0.5× 23 846
Jeremy P. Springhorn United States 13 444 0.7× 134 0.6× 101 0.6× 172 1.1× 181 1.3× 17 936
Ko Sasaki Japan 21 602 1.0× 78 0.3× 290 1.6× 207 1.3× 82 0.6× 78 1.3k
Zhong-Liang Deng China 5 673 1.1× 166 0.7× 103 0.6× 57 0.4× 116 0.8× 6 979

Countries citing papers authored by Alan R. Brooks

Since Specialization
Citations

This map shows the geographic impact of Alan R. Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan R. Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan R. Brooks more than expected).

Fields of papers citing papers by Alan R. Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan R. Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan R. Brooks. The network helps show where Alan R. Brooks may publish in the future.

Co-authorship network of co-authors of Alan R. Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of Alan R. Brooks. A scholar is included among the top collaborators of Alan R. Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan R. Brooks. Alan R. Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Brooks, Alan R., Luis Fernando Gamboa, Megan van Overbeek, et al.. (2024). Site-Specific Insertion of Factor VIII Gene Results in Durable Factor VIII Expression in Nonhuman Primates. Blood. 144(Supplement 1). 1055–1055. 1 indexed citations
2.
Cost, Gregory J., et al.. (2021). A Novel Type V CRISPR System with Potential for Genome Editing in the Liver. Blood. 138(Supplement 1). 1862–1862. 1 indexed citations
3.
Blasko, Eric, et al.. (2013). Hepatocyte clearance and pharmacokinetics of recombinant factor IX glycosylation variants. Biochemical and Biophysical Research Communications. 440(4). 485–489. 8 indexed citations
4.
5.
Petry, Harald, Linda Cashion, Paul Szymanski, et al.. (2006). Mx1 and IP-10: Biomarkers to Measure IFN- β Activity in Mice Following Gene-Based Delivery. Journal of Interferon & Cytokine Research. 26(10). 699–705. 16 indexed citations
6.
Schaefer, Caralee, Linda Cashion, Harald Petry, et al.. (2006). Gene-Based Delivery of IFN-β Is Efficacious in a Murine Model of Experimental Allergic Encephalomyelitis. Journal of Interferon & Cytokine Research. 26(7). 449–454. 11 indexed citations
7.
Qian, Hu Sheng, et al.. (2006). O52. iNOS-derived NO substitutes for endothelial NO in tumor angiogenesis and tumor growth in the absence of ecNOS expression. Nitric Oxide. 14(4). 16–16. 3 indexed citations
8.
Brooks, Alan R., Faye Wu, Perry Liu, et al.. (2006). 1078. Silencing of Transgene Expression Following Plasmid Based Delivery to Murine Skeletal Muscle Is Dose Dependent. Molecular Therapy. 13. S413–S413. 1 indexed citations
9.
Brooks, Alan R., Peter I. Lelkes, & Gabor M. Rubanyi. (2004). Gene Expression Profiling of Vascular Endothelial Cells Exposed to Fluid Mechanical Forces: Relevance for Focal Susceptibility to Atherosclerosis. Endothelium. 11(1). 45–57. 73 indexed citations
10.
Brooks, Alan R., et al.. (2004). Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle. The Journal of Gene Medicine. 6(4). 395–404. 268 indexed citations
11.
12.
Brooks, Alan R., Peter I. Lelkes, & Gabor M. Rubanyi. (2002). Gene expression profiling of human aortic endothelial cells exposed to disturbed flow and steady laminar flow. Physiological Genomics. 9(1). 27–41. 224 indexed citations
13.
Brooks, Alan R., Dov Shiffman, Christine Chan, Eric E. Brooks, & Peter G. Milner. (1996). Functional Analysis of the Human Cyclin D2 and Cyclin D3 Promoters. Journal of Biological Chemistry. 271(15). 9090–9099. 109 indexed citations
14.
Lee, Soon-Youl, et al.. (1996). Members of the Caudal Family of Homeodomain Proteins Repress Transcription from the Human Apolipoprotein B Promoter in Intestinal Cells. Journal of Biological Chemistry. 271(2). 707–718. 34 indexed citations
15.
Shiffman, Dov, Eric E. Brooks, Alan R. Brooks, Christine Chan, & Peter G. Milner. (1996). Characterization of the Human Cyclin-dependent Kinase 2 Gene. Journal of Biological Chemistry. 271(21). 12199–12204. 42 indexed citations
16.
Brooks, Alan R., et al.. (1994). Sequences Containing the Second-Intron Enhancer Are Essential for Transcription of the Human Apolipoprotein B Gene in the Livers of Transgenic Mice. Molecular and Cellular Biology. 14(4). 2243–2256. 47 indexed citations
17.
Brooks, Alan R. & Beatriz Levy-Wilson. (1992). Hepatocyte Nuclear Factor 1 and C/EBP Are Essential for the Activity of the Human Apolipoprotein B Gene Second-Intron Enhancer. Molecular and Cellular Biology. 12(3). 1134–1148. 6 indexed citations
18.
Old, Robert, Glen E. Sweeney, & Alan R. Brooks. (1988). Activity of a cloned Xenopus albumin gene promoter in the homologous frog oocyte system. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 951(1). 220–225. 1 indexed citations
19.
Sweeney, Glen E., Alan R. Brooks, Philip J. Day, & Robert Old. (1987). DNA sequence of the first exon and 5′ flanking region of the 68-K serum albumin gene ofXenopus laevis. Nucleic Acids Research. 15(14). 5889–5889. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola H. Dryden Breakdown of academic impact, for papers by Massimo Zani Breakdown of academic impact, for papers by Corinna Warburton Breakdown of academic impact, for papers by Aimee Landry Breakdown of academic impact, for papers by Sirous Zeinali Breakdown of academic impact, for papers by Masahiro Muto Breakdown of academic impact, for papers by Kenji Tamayose Breakdown of academic impact, for papers by Jeremy P. Springhorn Breakdown of academic impact, for papers by Ko Sasaki Breakdown of academic impact, for papers by Zhong-Liang Deng
Rankless by CCL
2026